Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
暂无分享,去创建一个
A. Skene | E. Braunwald | A. Budaj | D. Morrow | S. Murphy | C. McCabe | B. Scirica | E. Karwatowska-Prokopczuk | S. Varshavsky | A. Wolff | C. Mccabe
[1] B. Chaitman,et al. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials. , 2007, The American journal of cardiology.
[2] P. Stone,et al. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. , 2006 .
[3] J. Shryock,et al. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine , 2006, Heart.
[4] A. Skene,et al. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. , 2006, American heart journal.
[5] B. Chaitman. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. , 2006, Circulation.
[6] M. Pfeffer,et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. , 2004, JAMA.
[7] Andrew C. Zygmunt,et al. Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties , 2004, Circulation.
[8] B. Chaitman,et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. , 2004, Journal of the American College of Cardiology.
[9] B. Chaitman,et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. , 2004, JAMA.
[10] J. LeLorier,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[11] R. Gibbons. ACC/AHA guideline for management of patients with chronic stable angina , 2003 .
[12] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Journal of the American College of Cardiology.
[13] J. W. Schaeffer,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article , 2002 .
[14] Carl J Pepine,et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.
[15] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[16] J. Spertus,et al. Health Status Predicts Long-Term Outcome in Outpatients With Coronary Disease , 2002, Circulation.
[17] E. Antman,et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.
[18] E. Braunwald,et al. Unstable angina: an etiologic approach to management. , 1998, Circulation.
[19] J. Mccormack,et al. Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. , 1994, Cardiovascular research.
[20] T R Fleming,et al. Designs for group sequential tests. , 1984, Controlled clinical trials.
[21] P. David. [Institute of cardiology]. , 1952, L'union medicale du Canada.